Overview: Cryptosporidium Antigen (Crypto Ag Stool) TestIntroduction: The Cryptosporidium Antigen Test detects Cryptosporidium antigens, indicating parasitic infection causing diarrhea or abdominal pain. Following 2023 IDSA guidelines, it uses antigen detection for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in parasitology for patients with suspected parasitic infections, especially in immunocompromised populations.
Other Names: Cryptosporidium Antigen Assay, Stool Parasite Test.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic accuracy.
Historical Milestone: Cryptosporidium antigen testing began in the 1990s with parasitic research. Antigen detection methods emerged in the 2000s, improving diagnostic accuracy for diarrhea-related infections.
Purpose: Diagnoses Cryptosporidium infection, guides antiparasitic therapy, and monitors antigen presence in patients with diarrhea or abdominal pain.
Test Parameters: 1. Cryptosporidium Antigen
Pretest Condition: No fasting required. Collect stool at any time. Report symptoms like diarrhea or abdominal pain, and list immunocompromising conditions or recent travel.
Specimen: 5-10 g stool (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document diarrhea, abdominal pain, or immunocompromised states (e.g., HIV, chemotherapy). Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiparasitic therapy.
Procedural Considerations: Uses antigen detection (e.g., ELISA) to identify Cryptosporidium antigens. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Low antigen levels or improper storage can cause false negatives. Contamination may affect results.
Clinical Significance: Positive antigen results confirm Cryptosporidium infection, prompting antiparasitic therapy. Negative results may require PCR or microscopy.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A gastroenterologist referral is advised for severe diarrhea.
Additional Supporting Tests: Cryptosporidium PCR, stool microscopy, or ova and parasite exam to confirm infection.
Test Limitations: False negatives may occur with low antigen levels. Results require clinical correlation.
References: IDSA Parasitic Infection Guidelines, 2023; Clinical Infectious Diseases, White AC, 2022.
